Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFatigue after a Wegovy injection is one of the most commonly reported early side effects: it is real, it is recognised in the medicine's clinical data, and for most people it eases within a few days as the body adjusts to each new dose. Semaglutide slows gastric emptying and acts on appetite pathways in the brain, and that systemic shift takes energy. The decision most people face is not whether tiredness might happen, but how to manage it sensibly and how to tell normal adjustment from something that needs medical attention. Wegovy is a prescription-only medicine; a clinician assesses suitability and talks through what to expect before treatment begins. Our full Wegovy guide covers the broader picture if you are still weighing up whether this treatment is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works as a GLP-1 receptor agonist, mimicking the gut hormone GLP-1 to reduce appetite and slow the rate at which the stomach empties. That last effect is significant. When digestion slows, calorie intake drops, and blood-glucose levels shift, the body is doing a considerable amount of physiological recalibration — and that costs energy. On top of that, semaglutide crosses the blood-brain barrier and acts on hypothalamic pathways involved in energy regulation, which may contribute directly to feelings of tiredness, particularly in the first 24 to 48 hours after an injection. The NHS medicines page for semaglutide lists fatigue as a known side effect alongside the more widely discussed gastrointestinal symptoms. Most people find tiredness peaks shortly after injecting and then fades as the week progresses. After a dose increase it can temporarily return. That pattern (predictable, front-loaded, self-resolving) is what distinguishes ordinary adjustment from a reason to pause. If you want to understand the wider injection experience, the Wegovy injection guide on this site walks through technique, timing and what to expect at each stage.
A question our prescribers hear most weeks is whether anything can be done to take the edge off tiredness without stopping treatment. The answer is yes, and it mostly comes down to the things happening alongside the injection rather than the injection itself. Eating too little protein while appetite is suppressed is a common culprit, muscle requires adequate protein to maintain, and without it energy levels can drop further than the medicine alone would cause. Mild dehydration compounds this significantly; nausea can put people off drinking enough, and even modest fluid loss amplifies fatigue. Sleep disruption related to GI discomfort is another factor worth tracking. Practically, timing the injection in the evening means peak tiredness overnight rather than during the working day, though this is a personal preference, and the prescriber should be part of that conversation. This companion page on tiredness after Wegovy looks more closely at lifestyle adjustments that can help during the adjustment phase. It is also worth knowing that fatigue tends to diminish substantially once the body has had several weeks at a stable dose, which is part of why the titration schedule exists in the first place.
Ordinary post-injection fatigue is low-grade and passes. The signs that it has moved into different territory are fairly distinct. Extreme exhaustion that does not ease after a day or two, particularly if accompanied by severe or persistent stomach pain that radiates towards the back, should be assessed urgently, that combination can indicate acute pancreatitis, which the MHRA highlighted in a January 2026 Drug Safety Update as an infrequent but serious risk with GLP-1 medicines. Fatigue alongside repeated vomiting raises the possibility of dehydration and, in turn, strain on the kidneys; seek medical advice if you cannot keep fluids down for more than 24 hours. A fast heart rate, dizziness on standing, or very dark urine alongside tiredness are warning signs of significant fluid loss. Signs of an allergic reaction (swelling of the face, difficulty breathing, a widespread rash) require emergency help. Injection-site issues such as a lump or hard area under the skin are usually benign, but if the site is hot, swollen or painful beyond the usual tenderness, this page on injection-site lumps explains what to watch for and when to contact a clinician. If you are unsure whether what you are experiencing is normal, contact the team rather than waiting.
Fatigue as a side effect is real, but it sits in context. The STEP 1 trial, published in the New England Journal of Medicine (68 weeks, 2.4 mg semaglutide), found average weight loss of around 15%, a clinically meaningful result that for many participants changed how they felt about energy in the longer term, even if the first weeks felt harder. Side effects including tiredness were generally described as mild to moderate and transient. Understanding how long after starting you might expect to feel the benefit can help put early tiredness in perspective; this page on when Wegovy begins to work sets out a realistic timeline. If cost or eligibility is something you are still considering alongside everything else, the Wegovy cost page explains what private treatment includes and how pricing works. For people exploring the broader landscape of weight-loss injections, our comparison of weight-loss injection options gives an evidence-led overview. At nume, every consultation is reviewed personally by a GPhC-registered prescriber, they will discuss your specific circumstances, including how to manage side effects like fatigue, as part of deciding whether treatment is clinically appropriate for you. Start your free consultation whenever you are ready to talk it through.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.